The role of transforming growth factor beta signaling in messenger RNA stability

References

• Altmann M, Edery I, Sonenberg N, Trachsel H. Purification and characterization of protein synthesis initiation factor eIF-4E from the yeast Saccharomyces cerevisiae. Biochemistry 1985; 24: 6085–6089
   PubMed Web of Science ®Google Scholar
• Amara FM, Chen FY, Wright JA. A novel transforming growth factor-beta 1 responsive cytoplasmic trans-acting factor binds selectively to the 3′-untranslated region of mammalian ribonucleotide reductase R2 mRNA: Role in message stability. Nucleic Acids Res 1993; 21: 4803–4809
   PubMed Web of Science ®Google Scholar
• Amara FM, Chen FY, Wright JA. Defining a novel cis-element in the 3′-untranslated region of mammalian ribonucleotide reductase component R2 mRNA: Role in transforming growth factor-beta 1 induced mRNA stabilization. Nucleic Acids Res 1995; 23: 1461–1467
   PubMed Web of Science ®Google Scholar
• Amara FM, Entwistle J, Kuschak TI, Turley EA, Wright JA. Transforming growth factor-beta1 stimulates multiple protein interactions at a unique cis-element in the 3′-untranslated region of the hyaluronan receptor RHAMM mRNA. J Biol Chem 1996; 271: 15279–15284
   PubMed Web of Science ®Google Scholar
• Amara FM, Junaid A, Clough RR, Liang B. TGF-beta(1), regulation of alzheimer amyloid precursor protein mRNA expression in a normal human astrocyte cell line: mRNA Stabilization. Brain Res Mol Brain Res 1999; 71: 42–49
   PubMedGoogle Scholar
• Amara FM, Smith GM, Kuschak TI, Takeuchi TL, Wright JA. A cis–trans interaction at the 3′-untranslated region of ribonucleotide reductase mRNA is regulated by TGF-beta 1, TGF-beta 2, and TGF-beta 3. Biochem Biophys Res Commun 1996; 228: 347–351
   PubMed Web of Science ®Google Scholar
• Arici A, MacDonald PC, Casey ML. Modulation of the levels of interleukin-8 messenger ribonucleic acid and interleukin-8 protein synthesis in human endometrial stromal cells by transforming growth factor-beta 1. J Clin Endocrinol Metab 1996; 81: 3004–3009
   PubMed Web of Science ®Google Scholar
• Bascom CC, Wolfshohl JR, Coffey RJ, Jr, Madisen L, Webb NR, Purchio AR, Derynck R, Moses HL. Complex regulation of transforming growth factor beta 1, beta 2, and beta 3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors beta 1 and beta 2. Mol Cell Biol 1989; 9: 5508–5515
   PubMed Web of Science ®Google Scholar
• Benitez-Verguizas J, Loarte D, de Miguel F, Esbrit P. Effects of transforming growth factor beta1 on cell growth and parathyroid hormone-related protein in Walker 256 tumor cells. Life Sci 1999; 65: 1807–1816
   PubMed Web of Science ®Google Scholar
• Ben-Levy R, Hooper S, Wilson R, Paterson HF, Marshall CJ. Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2. Curr Biol 1998; 8: 1049–1057
   PubMed Web of Science ®Google Scholar
• Binder R, Hwang SP, Ratnasabapathy R, Williams DL. Degradation of apolipoprotein II mRNA occurs via endonucleolytic cleavage at 5′-AAU-3′/5′-UAA-3′ elements in single-stranded loop domains of the 3′-noncoding region. J Biol Chem 1989; 264: 16910–16918
   PubMed Web of Science ®Google Scholar
• Birkey Reffey S, Wurthner JU, Parks WT, Roberts AB, Duckett CS. X-linked inhibitor of apoptosis protein functions as a cofactor in transforming growth factor-beta signaling. J Biol Chem 2001; 276: 26542–26549
   PubMed Web of Science ®Google Scholar
• Bollig F, Winzen R, Gaestel M, Kostka S, Resch K, Holtmann H. Affinity purification of ARE-binding proteins identifies polyA-binding protein 1 as a potential substrate in MK2-induced mRNA stabilization. Biochem Biophys Res Commun 2003; 301: 665–670
   PubMed Web of Science ®Google Scholar
• Burton TR, Kashour T, Wright JA, Amara FM. Cellular signaling pathways affect the function of ribonucleotide reductase mRNA binding proteins: mRNA stabilization, drug resistance, and malignancy (Review). Int J Oncol 2003; 22: 21–31
   PubMed Web of Science ®Google Scholar
• Cai F, Campana WM, Tomlinson DR, Fernyhough P. Transforming growth factor-beta1 and glial growth factor 2 reduce neurotrophin-3 mRNA expression in cultured Schwann cells via a cAMP-dependent pathway. Brain Res Mol Brain Res 1999; 71: 256–264
   PubMedGoogle Scholar
• Cao H, Dzineku F, Blackshear PJ. Expression and purification of recombinant tristetraprolin that can bind to tumor necrosis factor-alpha mRNA and serve as a substrate for mitogen-activated protein kinases. Arch Biochem Biophys 2003; 412: 106–120
   PubMed Web of Science ®Google Scholar
• Carballo E, Cao H, Lai WS, Kennington EA, Campbell D, Blackshear PJ. Decreased sensitivity of tristetraprolin-deficient cells to p38 inhibitors suggests the involvement of tristetraprolin in the p38 signaling pathway. J Biol Chem 2001; 276: 42580–42587
   PubMed Web of Science ®Google Scholar
• Chang HY, Nishitoh H, Yang X, Ichijo H, Baltimore D. Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. Science 1998; 281: 1860–1863
   PubMed Web of Science ®Google Scholar
• Cheifetz S, Hernandez H, Laiho M, ten Dijke P, Iwata KK. Massague J. Distinct transforming growth factor-beta (TGF-beta) receptor subsets as determinants of cellular responsiveness to three TGF-beta isoforms. J Biol Chem 1990; 265: 20533–20538
   PubMed Web of Science ®Google Scholar
• Chen CY, Gherzi R, Andersen JS, Gaietta G, Jurchott K, Royer HD, Mann M, Karin M. Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation. Genes Dev 2000; 14: 1236–1248
   PubMedGoogle Scholar
• Davidson JM, Zang MC, Zoia O, Giro MG. Regulation of elastin synthesis in pathological states. Ciba Found Symp 1995; 192: 81–99
   PubMedGoogle Scholar
• Dean JL, Sarsfield SJ, Tsounakou E, Saklatvala J. p38 mitogen-activated protein kinase stabilises mRNAs that contain cyclooxygenase-2 and tumour necrosis factor AU-rich elements by inhibiting deadenylation. J Biol Chem 2003; 278: 39470–39476
   PubMed Web of Science ®Google Scholar
• Delany AM, Canalis E. The metastasis-associated metalloproteinase stromelysin-3 is induced by transforming growth factor-beta in osteoblasts and fibroblasts. Endocrinology 2001; 142: 1561–1566
   PubMed Web of Science ®Google Scholar
• Diaz A, Chepenik KP, Korn JH, Reginato AM, Jimenez SA. Differential regulation of cyclooxygenases 1 and 2 by interlukin-1 beta, tumor necrosis factor-alpha, and transforming growth factor-beta 1 in human lung fibroblasts. Exp Cell Res 1998; 241: 222–229
   PubMed Web of Science ®Google Scholar
• Du C, Sriram S. Mechanism of inhibition of LPS-induced IL-12p40 production by IL-10 and TGF-beta in ANA-1 cells. J Leukoc Biol 1998; 64: 92–97
   PubMed Web of Science ®Google Scholar
• Dubois CM, Ruscetti FW, Stankova J, Keller JR. Transforming growth factor-beta regulates c-kit message stability and cell-surface protein expression in hematopoietic progenitors. Blood 1994; 83: 3138–3145
   PubMed Web of Science ®Google Scholar
• Evdokimova V, Ruzanov P, Imataka H, Raught B, Svitkin Y, Ovchinnikov LP, Sonenberg N. The major mRNA-associated protein YB-1 is a potent 5′cap-dependent mRNA stabilizer. EMBO J 2001; 20: 5491–5502
   PubMed Web of Science ®Google Scholar
• Frevel MA, Bakheet T, Silva AM, Hissong JG, Khabar KS, Williams BR. p38 Mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts. Mol Cell Biol 2003; 23: 425–436
   PubMed Web of Science ®Google Scholar
• Gacheru SN, Thomas KM, Murray SA, Csiszar K, Smith-Mungo LI, Kagan HM. Transcriptional and post-transcriptional control of lysyl oxidase expression in vascular smooth muscle cells: effects of TGF-beta 1 and serum deprivation. J Cell Biochem 1997; 65: 395–407
   PubMed Web of Science ®Google Scholar
• Galera P, Vivien D, Pronost S, Bonaventure J, Redini F, Loyau G, et al. Transforming growth factor-beta 1 (TGF-beta 1) up-regulation of collagen type II in primary cultures of rabbit articular chondrocytes (RAC) involves increased mRNA levels without affecting mRNA stability and procollagen processing. J Cell Physiol 1992; 153: 596–606
   PubMed Web of Science ®Google Scholar
• Gao M, Fritz DT, Ford LP, Wilusz J. Interaction between a poly(A)-specific ribonuclease and the 5′ cap influences mRNA deadenylation rates in vitro. Mol Cell 2000; 5: 479–488
   PubMed Web of Science ®Google Scholar
• Hanafusa H, Ninomiya-Tsuji J, Masuyama N, Nishita M, Fujisawa J, Shibuya H, Matsumoto K, Nishida E. Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression. J Biol Chem 1999; 274: 27161–27167
   PubMed Web of Science ®Google Scholar
• Hara K, Yonezawa K, Weng QP, Kozlowski MT, Belham C, Avruch J. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J Biol Chem 1998; 273: 14484–14494, Erratum (1998) in: J Biol Chem 273:22160
   PubMed Web of Science ®Google Scholar
• Hayashi H, Inoue Y, Tsutsui H, Okamura H, Nakanishi K, Onozaki K. TGFbeta down-regulates IFN-gamma production in IL-18 treated NK cell line LNK5E6. Biochem Biophys Res Commun 2003; 300: 980–985
   PubMed Web of Science ®Google Scholar
• Heinrich MC, Dooley DC, Keeble WW. Transforming growth factor beta 1 inhibits expression of the gene products for steel factor and its receptor (c-kit). Blood 1995; 85: 1769–1780
   PubMed Web of Science ®Google Scholar
• Heldin CH, Miyazono K, ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 1994; 390: 465–471
   Google Scholar
• Hildenbrand R, Jansen C, Wolf G, Bohme B, Berger S, von Minckwitz G, Horlin A, Kaufman M, Stutte HJ. Transforming growth factor-beta stimulates urokinase expression in tumor-associated macrophages of the breast. Lab Invest 1998; 78: 59–71
   PubMed Web of Science ®Google Scholar
• Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K, Gotoh Y. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 1997; 275: 90–94
   PubMed Web of Science ®Google Scholar
• Inoki K, Li Y, Xu T, Guan KL. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 2003; 17: 1829–1834
   PubMed Web of Science ®Google Scholar
• Inoki K, Li Y, Zhu T, Wu J, Guan KL. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signaling. Nat Cell Biol 2002; 4: 648–657
   PubMed Web of Science ®Google Scholar
• Inoue K, Nakamura K, Abe K, Hirakawa T, Tsuchiya M, Matsuda H, et al. Effect of transforming growth factor beta on the expression of luteinizing hormone receptor in cultured rat granulosa cells. Biol Reprod 2002; 67: 610–615
   PubMed Web of Science ®Google Scholar
• Kahari VM, Olsen DR, Rhudy RW, Carrilo P, Chen YQ, Uitto J. Transforming growth factor-beta up-regulates elastin gene expression in human skin fibroblasts. Evidence of post-transcriptional modulation. Lab Invest 1992; 66: 580–588
   PubMed Web of Science ®Google Scholar
• Kehlen A, Langner J, Riemann D. Transforming growth factor-beta increases the expression of aminopeptidase N/CD13 mRNA and protein in monocytes and monocytic cell lines. Adv Exp Med Biol 2000; 477: 49–56
   PubMed Web of Science ®Google Scholar
• Kotlyarov A, Gaestel M. Is MK2 (mitogen-activated protein kinase-activated protein kinase 2) the key for understanding post-transcriptional regulation of gene expression?. Biochem Soc Trans 2002; 30: 959–963
   PubMed Web of Science ®Google Scholar
• Kucich U, Rosenbloom JC, Abrams WR, Bashir MM, Rosenbloom J. Stabilization of elastin mRNA by TGF-beta: Initial characterization of signaling pathway. Am J Respir Cell Mol Biol 1997; 17: 10–16
   PubMed Web of Science ®Google Scholar
• Kucich U, Rosenbloom JC, Abrams WR, Rosenbloom J. Transforming growth factor-beta stabilizes elastin mRNA by a pathway requiring active Smads, protein kinase C-delta, and p38. Am J Respir Cell Mol Biol 2002; 26: 183–188
   PubMed Web of Science ®Google Scholar
• Kucich U, Rosenbloom JC, Shen G, Abrams WR, Blaskovich MA, Hamilton AD, et al. Requirement for geranylgeranyl transferase I and acyl transferase in the TGF-beta-stimulated pathway leading to elastin mRNA stabilization. Biochem Biophys Res Commun 1998; 252: 111–116
   PubMed Web of Science ®Google Scholar
• Lee SD, Lee DS, Chun YG, Paik SH, Kim WS, Kim DS, Kim WD, Tuder RM, Voekel NF. Transforming growth factor-beta1 induces endothelin-1 in a bovine pulmonary artery endothelial cell line and rat lungs via cAMP. Pulm Pharmacol Ther 2000a; 13: 257–265
   PubMed Web of Science ®Google Scholar
• Lee J, Mira-Arbibe L, Ulevitch RJ. TAK1 regulates multiple protein kinase cascades activated by bacterial lipopolysaccharide. J Leukoc Biol 2000b; 68: 909–915
   PubMed Web of Science ®Google Scholar
• Liu S, Cieslinski DA, Funke AJ, Humes HD. Transforming growth factor-beta 1 regulates the expression of Pax-2, a developmental control gene, in renal tubule cells. Exp Nephrol 1997; 5: 295–300
   PubMedGoogle Scholar
• Liu C, Wallace K, Shi C, Heyner S, Komm B, Haddad JG. Post-transcriptional stimulation of transforming growth factor beta 1 mRNA by TGF-beta 1 treatment of transformed human osteoblasts. J Bone Miner Res 1996; 11: 211–217
   PubMed Web of Science ®Google Scholar
• Lo J, Hurta RA. Transforming growth factor beta1 selectively regulates ferritin gene expression in malignant H-ras-transformed fibrosarcoma cell lines. Biochem Cell Biol 2000; 78: 527–535
   PubMedGoogle Scholar
• McGowan SE, Jackson SK, Olson PJ, Parekh T, Gold LI. Exogenous and endogenous transforming growth factors-beta influence elastin gene expression in cultured lung fibroblasts. Am J Respir Cell Mol Biol 1997; 17: 25–35
   PubMed Web of Science ®Google Scholar
• Ming XF, Kaiser M, Moroni C. c-jun N-terminal kinase is involved in AUUUA-mediated interleukin-3 mRNA turnover in mast cells. EMBO J 1998; 17: 6039–6048
   PubMed Web of Science ®Google Scholar
• Miyoshi E, Nishikawa A, Ihara Y, Saito H, Uozumi N, Hayashi N, Fusamoto H, Kamada T, Taniguchi N. Transforming growth factor beta up-regulates expression of the N-acetylglucosaminyltransferase V gene in mouse melanoma cells. J Biol Chem 1995; 270: 6216–6220
   PubMed Web of Science ®Google Scholar
• Moriguchi T, Gotoh Y, Nishida E. Roles of the MAP kinase cascade in vertebrates. Adv Pharmacol 1996; 36: 121–137
   PubMedGoogle Scholar
• Murakami S, Nifuji A, Noda M. Expression of Indian hedgehog in osteoblasts and its posttranscriptional regulation by transforming growth factor-beta. Endocrinology 1997; 138: 1972–1978
   PubMed Web of Science ®Google Scholar
• Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, et al. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad. EMBO J 1997; 16: 5353–5362
   PubMed Web of Science ®Google Scholar
• Okamoto M, Ono M, Uchiumi T, Ueno H, Kohno K, Sugimachi K, Kuwano M. Up-regulation of thrombospondin-1 gene by epidermal growth factor and transforming growth factor beta in human cancer cells-transcriptional activation and messenger RNA stabilization. Biochim Biophys Acta 2002; 1574: 24–34
   PubMedGoogle Scholar
• Overall CM, Wrana JL, Sodek J. Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. J Biol Chem 1991; 266: 14064–14071
   PubMed Web of Science ®Google Scholar
• Palcy S, Goltzman D. Protein kinase signalling pathways involved in the up-regulation of the rat alpha1(I) collagen gene by transforming growth factor beta1 and bone morphogenetic protein 2 in osteoblastic cells. Biochem J 1999; 343: 21–27
   PubMed Web of Science ®Google Scholar
• Park JI, Lee MG, Cho K, Park BJ, Chae KS, Byun DS, Ryu BK, Park YK, Chi SG. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways. Oncogene 2003; 22: 4314–4332
   PubMed Web of Science ®Google Scholar
• Pasche B. Role of transforming growth factor beta in cancer. J Cell Physiol 2001; 186: 153–168
   PubMed Web of Science ®Google Scholar
• Perlman R, Schiemann WP, Brooks MW, Lodish HF, Weinberg RA. TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat Cell Biol 2001; 3: 708–714
   PubMed Web of Science ®Google Scholar
• Quintela M, Senaris RM, Dieguez C. Transforming growth factor-betas inhibit somatostatin messenger ribonucleic acid levels and somatostatin secretion in hypothalamic cells in culture. Endocrinology 1997; 138: 4401–4409
   PubMed Web of Science ®Google Scholar
• Raghow R, Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH. Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. J Clin Investig 1987; 79: 1285–1288
   PubMed Web of Science ®Google Scholar
• Rane MJ, Coxon PY, Powell DW, Webster R, Klein JB, Pierce W, Ping P, McLeish KR. p38 Kinase-dependent MAPKAPK-2 activation functions as 3-phosphoinositide-dependent kinase-2 for Akt in human neutrophils. J Biol Chem 2001; 276: 3517–3523
   PubMed Web of Science ®Google Scholar
• Ricupero DA, Poliks CF, Rishikof DC, Cuttle KA, Kuang PP, Goldstein RH. Phosphatidylinositol 3-kinase-dependent stabilization of alpha1(I) collagen mRNA in human lung fibroblasts. Am J Physiol Cell Physiol 2001; 281: C99–C105
   PubMed Web of Science ®Google Scholar
• Rodriguez C, Chen F, Weinberg RA, Lodish HF. Cooperative binding of transforming growth factor (TGF)-beta 2 to the types I and II TGF-beta receptors. J Biol Chem 1995; 270: 15919–15922
   PubMed Web of Science ®Google Scholar
• Ross J. mRNA Stability in mammalian cells. Microbiol Rev 1995; 59: 423–450
   PubMedGoogle Scholar
• Schluns KS, Cook JE, Le PT. TGF-beta differentially modulates epidermal growth factor-mediated increases in leukemia-inhibitory factor, IL-6, IL-1 alpha, and IL-1 beta in human thymic epithelial cells. J Immunol 1997; 158: 2704–2712
   PubMed Web of Science ®Google Scholar
• Sehgal I, Thompson TC. Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-beta1 in human prostate cancer cell lines. Mol Biol Cell 1999; 10: 407–416
   PubMed Web of Science ®Google Scholar
• Sellers RS, Capen CC, Rosol TJ. Messenger RNA stability of parathyroid hormone-related protein regulated by transforming growth factor-beta1. Mol Cell Endocrinol 2002; 188(1-2)37–46
   PubMed Web of Science ®Google Scholar
• Sheng H, Shao J, Dixon DA, Williams CS, Prescott SM, DuBois RN, et al. Transforming growth factor-beta1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA. J Biol Chem 2000; 275: 6628–6635
   PubMed Web of Science ®Google Scholar
• Sheng H, Shao J, Dubois RN. K-Ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase B1. Cancer Res 2001; 61: 2670–2675
   PubMed Web of Science ®Google Scholar
• Sherer TB, Neff PS, Tuttle JB. Increased nerve growth factor mRNA stability may underlie elevated nerve growth factor secretion from hypertensive vascular smooth muscle cells. Brain Res Mol Brain Res 1998a; 62: 167–174
   PubMedGoogle Scholar
• Sherer TB, Neff PS, Hankins GR, Tuttle JB. Mechanisms of increased NGF production in vascular smooth muscle of the spontaneously hypertensive rat. Exp Cell Res 1998b; 241: 186–193
   PubMed Web of Science ®Google Scholar
• Shibuya H, Yamaguchi K, Shirakabe K, Tonegawa A, Gotoh Y, Ueno N, Irie K, Nishida E, Matsumoto K. TAB1: An activator of the TAK1 MAPKKK in TGF-beta signal transduction. Science 1996; 272: 1179–1182
   PubMed Web of Science ®Google Scholar
• Shirakabe K, Yamaguchi K, Shibuya H, Irie K, Matsuda S, Moriguchi T, Gotoh Y, Matsumoto K, Nishida E. TAK1 mediates the ceramide signaling to stress-activated protein kinase/c-Jun N-terminal kinase. J Biol Chem 1997; 272: 8141–8144
   PubMed Web of Science ®Google Scholar
• Singer CA, K J, McCaffrey A, AuCoin DP, Dechert MA, Gerthoffer WT. p38 MAPK and NF-{kappa}B Mediate COX-2 expression in human airway myocytes. Am J Physiol Lung Cell Mol Physiol 2003; 285: 1087–1097
   Web of Science ®Google Scholar
• Smith WB, Noack L, Khew-Goodall Y, Isenmann S, Vadas MA, Gamble JR. Transforming growth factor-beta 1 inhibits the production of IL-8 and the transmigration of neutrophils through activated endothelium. J Immunol 1996; 157: 360–368
   PubMed Web of Science ®Google Scholar
• Song QH, Klepeis VE, Nugent MA, Trinkaus-Randall V. TGF-beta1 regulates TGF-beta1 and FGF-2 mRNA expression during fibroblast wound healing. Mol Pathol 2002; 55: 164–176
   PubMedGoogle Scholar
• Story MT, Hopp KA, Meier DA. Regulation of basic fibroblast growth factor expression by transforming growth factor beta in cultured human prostate stromal cells. Prostate 1996; 28: 219–226
   PubMed Web of Science ®Google Scholar
• Suberville S, Bellocq A, Peguillet I, Lantz O, Stordeur P, Fouqueray B, et al. Transforming growth factor-beta inhibits interleukin-10 synthesis by human monocytic cells. Eur Cytokine Netw 2001; 12: 141–146
   PubMed Web of Science ®Google Scholar
• Tannehill-Gregg S, Kergosien E, Rosol TJ. Feline head and neck squamous cell carcinoma cell line: characterization, production of parathyroid hormone-related protein, and regulation by transforming growth factor-beta. In Vitro Cell Dev Biol Anim 2001; 37: 676–683
   PubMed Web of Science ®Google Scholar
• Tee AR, Manning BD, Roux PP, Cantley LC, Blenis J. Tuberous Sclerosis complex gene products tuberin and hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr Biol 2003; 13: 1259–1268
   PubMed Web of Science ®Google Scholar
• Ten Dijke P, Goumans MJ, Itoh F, Itoh S. Regulation of cell proliferation by Smad proteins. J Cell Physiol 2002; 191: 1–16
   PubMed Web of Science ®Google Scholar
• Uchiyama-Tanaka Y, Matsubara H, Mori Y, Kosaki A, Kishimoto N, Amano K, Higashiyama S, Iwasaka T. Involvement of HB-EGF and EGF receptor transactivation in TGF-beta-mediated fibronectin expression in mesangial cells. Kidney Int 2002; 62: 799–808
   PubMed Web of Science ®Google Scholar
• Vodovotz Y, Bogdan C, Paik J, Xie QW, Nathan C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J Exp Med 1993; 178: 605–613
   PubMed Web of Science ®Google Scholar
• Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 2001; 412: 346–351
   PubMed Web of Science ®Google Scholar
• Werkmeister JR, Blomme EA, Weckmann MT, Grone A, McCauley LK, Wade AB, O'Rourke J, Capen CC, Rosal TJ. Effect of transforming growth factor-beta1 on parathyroid hormone-related protein secretion and mRNA expression by normal human keratinocytes in vitro. Endocrine 1998; 8: 291–299
   PubMed Web of Science ®Google Scholar
• Williams G, Becker L, Bryant D, Willis S, Giroir BP. Effects of transforming growth factor-beta 1 on nitric oxide synthesis by C2C12 skeletal myocytes. Am J Physiol 1996; 270: R145–R152
   Google Scholar
• Winzen R, Kracht M, Ritter B, Wilhelm A, Chen CY, Shyu AB, Muller M, Gaestel M, Resch K, Holtmann H. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J 1999; 18: 4969–4980
   PubMed Web of Science ®Google Scholar
• Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J. Mechanism of activation of the TGF-β receptor. Nature 1994; 370: 341–347
   PubMed Web of Science ®Google Scholar
• Wrana JL, Overall CM, Sodek J. Regulation of the expression of a secreted acidic protein rich in cysteine (SPARC) in human fibroblasts by transforming growth factor beta. Comparison of transcriptional and post-transcriptional control with fibronectin and type I collagen. Eur J Biochem 1991; 197: 519–528
   PubMedGoogle Scholar
• Yamaguchi K, Nagai S, Ninomiya-Tsuji J, Nishita M, Tamai K, Irie K, Ueno N, Nishida E, Shibuya H, Matsumoto K. XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway. EMBO J 1999; 18: 179–187
   PubMed Web of Science ®Google Scholar
• Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K. Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 1995; 270: 2008–2011
   PubMed Web of Science ®Google Scholar
• Yamashita H, ten Dijke P, Franzen P, Miyazono K, Heldin CH. Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-beta. J Biol Chem 1994; 269: 20172–20178
   PubMed Web of Science ®Google Scholar
• Yang X, Khosravi-Far R, Chang HY, Baltimore D. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 1997; 89: 1067–1076
   PubMed Web of Science ®Google Scholar
• Yuan W, Collado-Hidalgo A, Yufit T, Taylor M, Varga J. Modulation of cellular tryptophan metabolism in human fibroblasts by transforming growth factor-beta: Selective inhibition of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA synthetase gene expression. J Cell Physiol 1998; 177: 174–186
   PubMed Web of Science ®Google Scholar
• Yue J, Mulder KM. Activation of the mitogen-activated protein kinase pathway by transforming growth factor-beta. Methods Mol Biol 2000; 142: 125–131
   PubMedGoogle Scholar
• Zaidi SH, Malter JS. Nucleolin and heterogeneous nuclear ribonucleoprotein C proteins specifically interact with the 3′-untranslated region of amyloid protein precursor mRNA. J Biol Chem 1995; 270: 17292–17298
   PubMedGoogle Scholar
• Zhou G, Lee SC, Yao Z, Tan TH. Hematopoietic progenitor kinase 1 is a component of transforming growth factor beta-induced c-Jun N-terminal kinase signaling cascade. J Biol Chem 1999; 274: 13133–13138
   PubMed Web of Science ®Google Scholar